All In MedTech

Device Trial Radar · NCT04307992

AneuFix - Prophylactic Sac Filling

Feasibility Assessment of the Prophylactic Use of AneuFix at the Time of EVAR Implantation

Last checked: Nov 20, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

20

Planned (sponsor's estimate)

Start

Feb 15, 2022

Primary completion

Nov 30, 2026

Study completion Nov 30, 2027

Sponsor

Lead sponsor
TripleMed B.V.Not on our public-company list
Sponsor type
Industry
First posted
Mar 13, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is set up to assess the feasibility and safety of the clinical procedure using AneuFix in a prophylactic setting at the time of EVAR endograft implantation.

Conditions

  • Abdominal Aortic Aneurysm
  • Endoleak

Interventions

  • Prophylactic sac filling with AneuFixDevice

    ANEUFIX is administered by injection into the AAA via transferal access at the time of EVAR placement using imaging techniques to guide the place of injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Technical SuccessTime frame: 24 hours
  2. Clinical Success rateTime frame: 6 months
  3. Clinical Success rateTime frame: 12 months

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • VUmc

    Amsterdam, North Holland, Netherlands

  • Spaarne Gasthuis Haarlem

    Haarlem, North Holland, Netherlands

  • ZGT Almelo

    Almelo, Overijssel, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.